Mike Zablocki
General Manager
Mike is General Manager of the Malaghan Institute, responsible for the corporate, commercial and support functions of the organisation. He is also a Director of Wellington Zhaotai Therapies Limited, a joint venture established by the Malaghan Institute to develop innovative cell therapies for the global market.
Mike completed a Bachelor of Arts at the University of Bristol, before moving to New Zealand in 2002 when he joined the Malaghan as a database administrator. In 2011 he completed his Postgraduate Diploma in Business Administration at Victoria University of Wellington. He was appointed as General Manager in 2016.
New research to help vaccines work better as we age
8 October 2026
Cancer: Same name, different diseases
23 September 2026
New clinical research core to help take research from benchtop to bedside
8 September 2026
Research offers new approach to vaccine design for broader immunity
27 August 2026
Reading the immune system, one puzzle piece at a time
26 August 2026
Clinical study to uncover the origins of a severe type of Crohn’s disease
26 August 2026
New research to help vaccines work better as we age
8 October 2026
Cancer: Same name, different diseases
23 September 2026
New clinical research core to help take research from benchtop to bedside
8 September 2026
Research offers new approach to vaccine design for broader immunity
27 August 2026
Reading the immune system, one puzzle piece at a time
26 August 2026
Clinical study to uncover the origins of a severe type of Crohn’s disease
26 August 2026